Pubblicazioni

Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials

2018 - ANNALS OF ONCOLOGY

de van der Schueren, M. A. E.; Laviano, A.; Blanchard, H.; Jourdan, M.; Arends, J.; Baracos, V. E.

Development of a new clinical nomogram including velocity rate of disease progression to predict outcome in metastatic colorectal cancer patients treated with bevacizumab beyond progression: A subanalysis from tribe trial

2018 - ANNALS OF ONCOLOGY

Dell'Aquila, E; Pantano, F; Rossini, D; Stellato, M; Lonardi, S; Masi, G; Schirripa, M; Marmorino, F; Antoniotti, C; Murgioni, S; Tomasello, G; Ronzoni, M; Racca, P; Vincenzi, B; Allegrini, G; Urbano, F; Buonadonna, A; Banzi, M; Tonini, G; Cremolini, C; Falcone, A; Santini, D

Synergistic effects of PARP inhibitors and ionizing radiation on growth and survival of rhabdomyosarcoma cells

2018 - ANNALS OF ONCOLOGY

Megiorni, F.; Camero, S.; Ceccarelli, S.; De Felice, F.; Marampon, F.; Pizer, B.; Shukla, R.; Tombolini, V.; Marchese, C.; Dominici, C.

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high dose cisplatin

2017 - ANNALS OF ONCOLOGY

Bossi, P; Cortinovis, D; Fatigoni, S; Cossu Rocca, M; Fabi, A; Seminara, Patrizia; Ripamonti, C; Alfieri, S; Granata, R; Bergamini, C; Agustoni, F; Bidoli, P; NolÃ¨, F; Pessi, M. A; Macchi, F; Michellini, L; Montanaro, F; Roila, F.

Borderline resectable pancreatic cancer. an evolving concept

2017 - ANNALS OF ONCOLOGY

Petrucciani, Niccolo'; Debs, T; Nigri, Giuseppe; D'Angelo, Francesco; Gugenheim, J; Ramacciato, Giovanni

Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer

2017 - ANNALS OF ONCOLOGY

Ciuffreda, L; DEL CURATOLO, ANAIS; Falcone, I; Conciatori, F; Bazzichetto, C; Cognetti, F; Corbo, V; Scarpa, A; Milella, M

M8Concomitant versus sequential Fotemustine and Bevacizumab in recurrent malignant gliomas: treatment response and survival outcomes in a retrospective analysis

2017 - ANNALS OF ONCOLOGY

Prelaj, A; Rebuzzi, S E; GirÃ²n BerrÃ¬os, J R; Pecorari, S; Fusto, C; Ferrara, C; Salvati, M; Tomao, S; Bianco, Vito

Radium-223 in metastatic castration-resistant prostate cancer (mCRPC):efficacy and safety in real-life experience

2017 - ANNALS OF ONCOLOGYANNALS OF ONCOLOGY

Rebuzzi, Se; Prelaj, A; Pozzi, C; Ferrara, C; Frantellizzi, V; Follacchio, Ga; de Vincentis, G; Tomao, S; Bianco, V

Management of CLL in the elderly

2017 - ANNALS OF ONCOLOGY

Cuneo, A; Foa, Roberto

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

2017 - ANNALS OF ONCOLOGY

Lonardi, S; Sobrero, A; Rosati, G; Di Bartolomeo, M; Ronzoni, M; Aprile, G; Massida, B; Scartozzi, M; Banzi, M; Zampino, M. G; Pasini, F; Marchetti, Paolo; Cantore, M; Zaniboni, A; Rimassa, L; Ciuffreda, L; Ferrari, D; Barni, S; Zagonel, V; Maiello, E; Rulli, E; Labianca, R.

D23Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres

2017 - ANNALS OF ONCOLOGY

Occhipinti, M; Botticelli, A; Onesti, C. E; Ghidini, M; Righini, R; Pizzo, C; Milano, A; Tomasello, Grazia; Di Pietro, F. R; Toppo, L; Ratti, M; Passalacqua, R; Marchetti, P; Mazzuca, F.

Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting

2017 - ANNALS OF ONCOLOGY

Ratta, R.; Verzoni, E.; Pantano, F.; Grassi, P.; De Lisi, D.; Onorato, A.; Prisciandaro, M.; Montone, R.; de Braud, F.; Santini, D.; Procopio, G.

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? (vol 23, pg 2313, 2012)

2017 - ANNALS OF ONCOLOGY

Santini, D; Vincenzi, B; Addeo, R; Garufi, C; Masi, G; Scartozzi, M; Mancuso, A; Frezza, Am; Venditti, O; Imperatori, M; Schiavon, G; Bronte, G; Cicero, G; Recine, F; Maiello, E; Cascinu, S; Russo, A; Falcone, A; Tonini, G

Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence

2017 - ANNALS OF ONCOLOGY

Caponnetto, S.; Gelibter, A.; Mosillo, C.; Magri, V.; Scagnoli, S.; Pomati, G.; Piesco, G.; Verkhovskaya, S.; Pisegna, S.; Sirgiovanni, G.; Napoli, V.; Buscicchio, D.; Iannantuono, G. M.; Marinelli, D.; Mammone, G.; Pannunzio, S.; Nicolo', E.; Stefani, A.; Astorino, V.; Mancini, M.; Cortesi, E.

Adjuvant treatment in elderly cancer patients: a multicenter real-life experience

2017 - ANNALS OF ONCOLOGY

Bassanelli, M.; Ceribelli, A.; Giannarelli, D.; Giacinti, S.; Viterbo, A.; Siringo, M.; Poti, G.; Roberto, M.; Macrini, S.; Falcone, R.; Giuli, A.; Di Pietro, F. R.; Aschelter, A. M.; Marchetti, P.

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer

2016 - ANNALS OF ONCOLOGY

Pruneri, G; Vingiani, A; Bagnardi, V; Rotmensz, N; De Rose, A; Palazzo, Antonella; Colleoni, A. M; Goldhirsch, A; Viale, G.

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials.ANNALS OF ONCOLOGY, ISSN: 0923-7534

2016 - ANNALS OF ONCOLOGY

Cremolini, C; Loupakis, F; Masi, G; Lonardi, S; Granetto, C; Mancini, Marialaura; Chiara, S; Moretto, R; Rossini, Daniela; Vitello, S; Allegrini, G; Tonini, G; Bergamo, F; Tomasello, G; Ronzoni, M; Buonadonna, A; Bustreo, S; Barbara, C; Boni, Maria Luisa; Falcone, A. 1. 5.

Perspectives of health care professionals on cancer cachexia: results from three global surveys

2016 - ANNALS OF ONCOLOGY

Muscaritoli, Maurizio; ROSSI FANELLI, Filippo; Molfino, Alessio

Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial

2016 - ANNALS OF ONCOLOGY

Ceccarelli, I; Schietroma, G; Corano Scheri, Giuseppe; D'Ettorre, Gabriella; Vullo, Vincenzo

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

2016 - ANNALS OF ONCOLOGY

Vitolo, U.; Seymour, J. F.; Martelli, Maurizio; Illerhaus, G.; Illidge, T.; Zucca, E.; Campo, E.; Ladetto, M.; on behalf of the ESMO Guidelines Committee, Null

Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group

2016 - ANNALS OF ONCOLOGY

Gronchi, A; Stacchiotti, S; Verderio, P; Ferrari, S; Martin Broto, J; Lopez Pousa, A; Llombart Bosch, A; Dei Tos, Ap; Collini, P; Jurado, Jc; De Paoli, A; Donati, Dm; Poveda, A; Quagliuolo, V; Comandone, A; Grignani, G; Morosi, C; Messina, A; De Sanctis, Rita; Bottelli, S; Palassini, E; Casali, Pg; Picci, P.

F295-fluorouracil degradation rate (5-FU-DR) could predict toxicity in breast cancer patients treated with capecitabine

2016 - ANNALS OF ONCOLOGY

Onesti, C. E.; Botticelli, A.; Mazzuca, F.; Angelini, S.; Petremolo, A.; Roberto, M.; Occhipinti, M.; Romiti, A.; Lionetto, L.; Simmaco, M.; Marchetti, P.

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

2016 - ANNALS OF ONCOLOGY

Lonardi, S.; Sobrero, A.; Rosati, G.; Di Bartolomeo, M.; Ronzoni, M.; Aprile, G.; Scartozzi, M.; Banzi, M.; Zampino, M. G.; Pasini, F.; Marchetti, P.; Cantore, M.; Zaniboni, A.; Rimassa, L.; Ciuffreda, L.; Ferrari, D.; Barni, S.; Zagonel, V.; Maiello, E.; Rulli, E.; Labianca, Roberto

S47A retrospective analysis to evaluted the off-label use Bevacizumab in recurrent malignant gliomas

2016 - ANNALS OF ONCOLOGY

Prelaj, A.; Rebuzzi, S. E.; Salvati, M.; Pozzi, Carolina; Ferrara, C.; Tomao, S.; Bianco, V.

P-158Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety

2016 - ANNALS OF ONCOLOGY

Cortesi, E.; Masi, G.; Mancini, M.; Caponnetto, S.; Urbano, F.; Mosillo, C.; Scagnoli, S.; Notarianni, E.; Pelle, G.; Vivaldi, C.; Falcone, A.; Cianni, R.